These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21819225)

  • 1. Public response to an anthrax attack: reactions to mass prophylaxis in a scenario involving inhalation anthrax from an unidentified source.
    SteelFisher G; Blendon R; Ross LJ; Collins BC; Ben-Porath EN; Bekheit MM; Mailhot JR
    Biosecur Bioterror; 2011 Sep; 9(3):239-50. PubMed ID: 21819225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public response to an anthrax attack: a multiethnic perspective.
    Steelfisher GK; Blendon RJ; Brulé AS; Ben-Porath EN; Ross LJ; Atkins BM
    Biosecur Bioterror; 2012 Dec; 10(4):401-11. PubMed ID: 23244501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of anthrax attacks on the American public.
    Blendon RJ; Benson JM; DesRoches CM; Pollard WE; Parvanta C; Herrmann MJ
    MedGenMed; 2002 Apr; 4(2):1. PubMed ID: 12145561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1051-4. PubMed ID: 11808926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    JAMA; 2001 Dec; 286(23):2935-6. PubMed ID: 11787481
    [No Abstract]   [Full Text] [Related]  

  • 6. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.
    Kyriacou DN; Dobrez D; Parada JP; Steinberg JM; Kahn A; Bennett CL; Schmitt BP
    Biosecur Bioterror; 2012 Sep; 10(3):264-79. PubMed ID: 22845046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Anthrax Postexposure Antibiotic Prophylaxis-The New York City Approach.
    Misener M; Starr DT; Scaccia AJ; Arya V
    Health Secur; 2018; 16(4):274-279. PubMed ID: 30133374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demand for prophylaxis after bioterrorism-related anthrax cases, 2001.
    Belongia EA; Kieke B; Lynfield R; Davis JP; Besser RE
    Emerg Infect Dis; 2005 Jan; 11(1):42-8. PubMed ID: 15705321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical counterbioterrorism: the response to provide anthrax prophylaxis to New York City US Postal Service employees.
    Partridge R; Alexander J; Lawrence T; Suner S
    Ann Emerg Med; 2003 Apr; 41(4):441-6. PubMed ID: 12658240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.
    Shepard CW; Soriano-Gabarro M; Zell ER; Hayslett J; Lukacs S; Goldstein S; Factor S; Jones J; Ridzon R; Williams I; Rosenstein N;
    Emerg Infect Dis; 2002 Oct; 8(10):1124-32. PubMed ID: 12396927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak.
    M'ikanatha NM; Julian KG; Kunselman AR; Aber RC; Rankin JT; Lautenbach E
    BMC Public Health; 2005 Jan; 5():2. PubMed ID: 15634353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001.
    Jefferds MD; Laserson K; Fry AM; Roy S; Hayslett J; Grummer-Strawn L; Kettel-Khan L; Schuchat A;
    Emerg Infect Dis; 2002 Oct; 8(10):1138-44. PubMed ID: 12396929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics for anthrax: patient requests and physician prescribing practices during the 2001 New York City attacks.
    Hupert N; Chege W; Bearman GM; Pelzman FN
    Arch Intern Med; 2004 Oct; 164(18):2012-6. PubMed ID: 15477436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Tool for Decision Support during Early Days of an Anthrax Event.
    Rainisch G; Meltzer MI; Shadomy S; Bower WA; Hupert N
    Emerg Infect Dis; 2017 Jan; 23(1):46-55. PubMed ID: 27983505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.
    Vietri NJ; Purcell BK; Lawler JV; Leffel EK; Rico P; Gamble CS; Twenhafel NA; Ivins BE; Heine HS; Sheeler R; Wright ME; Friedlander AM
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7813-6. PubMed ID: 16672361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001.
    Greene CM; Reefhuis J; Tan C; Fiore AE; Goldstein S; Beach MJ; Redd SC; Valiante D; Burr G; Buehler J; Pinner RW; Bresnitz E; Bell BP;
    Emerg Infect Dis; 2002 Oct; 8(10):1048-55. PubMed ID: 12396914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.